Bausch & Lomb appoints new chairman and CEO

Article

Former executives of Schering-Plough, Fred Hassan and Brent Saunders, have taken over the helm at Bausch & Lomb as chairman and CEO respectively.

Former executives of Schering-Plough, Fred Hassan and Brent Saunders, have taken over the helm at Bausch & Lomb as chairman and CEO respectively.

New CEO Saunders, in an interview with Associated Press, said: “The previous management should be commended for all the hard work it did to stabilize this company. I've been involved in a stabilization project myself in my past employer, and I know how difficult that can be. It's time for the company to look to the future with a mission of becoming 'not the biggest' but 'the best company in vision care,” Saunders continued.

“We'll be looking to do some tuck-in acquisitions, focused in looking for new products and new sciences and technologies to advance eye health.”

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.